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Association of Atrial Nicotinamide Adenine
Dinucleotide Phosphate Oxidase Activity With the
Development of Atrial Fibrillation After Cardiac Surgery
Young M. Kim, BSC,* Hassan Kattach, MRCS,† Chandi Ratnatunga, FRCS,† Ravi Pillai, FRCS,†
Keith M. Channon, MD, FRCP* Barbara Casadei, MD, DPHIL, FRCP*
Oxford, United Kingdom
Objectives Our goal was to evaluate the role of myocardial nicotinamide adenine dinucleotide phosphate (NADPH) oxidase
activity and plasma markers of oxidative stress in the pathogenesis of post-operative atrial fibrillation (AF).
Background Atrial fibrillation is a common complication of cardiac surgery, leading to increased morbidity and prolonged
hospitalization. Experimental evidence suggests that oxidative stress may be involved in the pathogenesis of AF;
however, the relevance of this putative mechanism in patients undergoing cardiac surgery is unclear.
Methods We measured basal and NADPH-stimulated superoxide production in right atrial appendage samples from 170
consecutive patients undergoing conventional coronary artery bypass surgery. Plasma markers of lipid and pro-
tein oxidation (thiorbabituric acid-reactive substances, 8-isoprostane, and protein carbonyls) were also measured
in blood samples drawn from a central line before surgery and after reperfusion.
Results Patients who developed AF after surgery (42%) were older and had a significantly increased atrial NADPH oxi-
dase activity than patients who remained in sinus rhythm (SR) (in relative light units/s/g protein: 4.78  1.44
vs. 3.53  1.04 in SR patients, p  0.0001). Plasma markers of lipid and protein oxidation increased signifi-
cantly after reperfusion; however, neither pre-operative nor post-operative measurements differed between pa-
tients who developed AF and those who remained in SR after surgery. Multivariate analysis identified atrial
NADPH oxidase activity as the strongest independent predictor of post-operative AF (odds ratio 2.41; 95% confi-
dence interval 1.71 to 3.40, p  0.0001).
Conclusions Atrial NADPH oxidase activity is independently associated with an increased risk of post-operative AF, suggesting
that this oxidase system may be a key mediator of atrial oxidative stress leading to the development of AF after
cardiac surgery. (J Am Coll Cardiol 2008;51:68–74) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.07.085m
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ttrial fibrillation (AF) is a frequent complication of most
ypes of cardiac surgery, occurring in 35% to 50% of patients
ithin the first 2 to 5 post-operative days (1,2). Post-
perative AF can induce hemodynamic deterioration, in-
rease the risk of stroke, and is invariably associated with
rolonged hospitalization and a significant additional cost
o patient care (1,2). Little is known of the mechanisms
nderlying post-operative AF, although emerging evidence
ndicates that inflammation and oxidative stress associated
ith cardiac surgery and cardiopulmonary bypass (CPB)
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he Garfield Weston Trust.n
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ccepted July 24, 2007.ay play an important role (3–6). It has recently been
eported that myocardial oxidative injury leads to impaired
trial contraction, altered myofibrillar energetics (7), and a
eduction in the atrial effective refractory period (AERP)
8), which, in turn, increases the vulnerability to AF (9).
See page 75
mportantly, short-term treatment with high doses of anti-
xidant and anti-inflammatory agents attenuates AERP
hortening and the vulnerability to AF in animal models of
apid atrial pacing (8,10,11), suggesting that atrial electro-
hysiological remodeling leading to AF may be prevented
y inhibiting the myocardial formation of reactive oxygen
pecies (ROS).
An increasing body of experimental evidence indicates
hat formation of the ROS, superoxide, by cardiovascular
icotinamide adenine dinucleotide phosphate (NADPH)
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January 1/8, 2008:68–74 Atrial NADPH Oxidase Activity and Post-Operative AFxidases plays a critical role in the development of hyper-
ension, myocardial hypertrophy, and heart failure (12). We
ave recently reported that human atrial myocytes have the
apacity to produce ROS via a phagocytic-type NADPH
xidase, and that NADPH-stimulated superoxide produc-
ion is increased in patients with sustained or paroxysmal
F (13). Nicotinamide adenine dinucleotide phosphate
xidase activity is potently stimulated by cytokines (12),
uggesting that this oxidase system may be an important
ink between the systemic inflammatory response to cardiac
urgery and myocardial oxidative stress.
Taken together, these data suggest that atrial NADPH
xidase activity may be a more sensitive predictor of ROS-
ediated myocardial electrophysiological changes leading to
ost-operative AF than plasma markers of oxidative stress.
o test this hypothesis, we prospectively evaluated the
elationship between ROS production in the right atrial
yocardium, plasma markers of protein and lipid oxidation,
nd the occurrence of post-operative AF in 170 consecutive
atients who underwent first-time elective coronary artery
ypass grafting (CABG) surgery.
ethods
ne hundred seventy consecutive patients undergoing
rst-time elective CABG surgery were recruited in this
linical and Demographic Characteristics
Table 1 Clinical and Demographic Characteristics
SR (n  99) AF (n  71) p Value
Pre-operative
Male gender (%) 75 (76) 57 (79) 0.68
Age (yrs) 67 7 69 7 0.04
Hypertension, n (%) 66 (67) 49 (68) 0.92
Diabetes mellitus, n (%) 23 (23) 20 (28) 0.52
Family history of CVD, n (%) 51 (52) 37 (51) 0.93
History of CHF, n (%) 12 (12) 9 (13) 0.91
Previous MI, n (%) 46 (47) 35 (49) 0.83
Current smokers, n (%) 13 (13) 7 (10) 0.48
History of COPD, n (%) 10 (10) 7 (10) 0.96
Aspirin, n (%) 82 (84) 62 (86) 0.65
Beta-blockers, n (%) 73 (74) 55 (76) 0.78
Diuretics, n (%) 23 (23) 24 (33) 0.15
Nitrates, n (%) 58 (59) 45 (62) 0.66
ACEI/ARB, n (%) 62 (63) 50 (69) 0.40
CCB, n (%) 39 (40) 24 (33) 0.39
Statins, n (%) 89 (91) 67 (93) 0.60
Intra-operative
CPB, min 61 18 62 25 0.72
ACC, min 30 11 30 8 0.99
Number of grafts 3 1 3 1 0.93
Post-operative
Inotropic support, n (%) 40 (40) 35 (49) 0.40
Start of ACEI/ARB treatment (day) 3.6 2.7 3.8 2.8 0.75
Start of beta-blocker treatment (day) 2.5 1.7 3.3 2.7 0.05
CC  aortic clamp time; ACEI  angiotensin-converting enzyme inhibitor; AF  atrial fibrillation;
RB  angiotensin II receptor blocker; CCB  calcium-channel blocker; CHF  congestive heartl
ailure; COPD  chronic obstructive pulmonary disease; CPB  cardiopulmonary bypass time;
VD  cardiovascular disease; MI  myocardial infarction; SR  sinus rhythm.tudy. Exclusion criteria were a
receding history of AF or
ther atrial arrhythmias, con-
omitant valvular disease, and
he use of anti-arrhythmic
rugs other than beta-blockers.
he demographic and clinical
haracteristics of the patients
re shown in Table 1. Patients
ere asked to withdraw treat-
ent with aspirin 3 days before
urgery. Similar surgical and
nesthetic protocols were fol-
owed in all patients. All
ABG procedures were per-
ormed using the on-pump
echnique. Post-operatively,
eart rate and rhythm were
ontinuously monitored for the
rst 48 h and at 4-h intervals
hereafter for 5 days. Post-
perative AF was defined as the
haracteristic arrhythmia last-
ng for at least 30 s. The study
as approved by the local re-
earch ethics committee, and all patients gave written
nformed consent.
easurements of superoxide production in right atrial
ppendage (RAA) homogenates. A sample of the RAA
as obtained in all patients at the time of venous
annulation, before the initiation of CPB. Superoxide
roduction was measured in homogenized RAA tissue by
ucigenin-enhanced chemiluminescence using a single
ube luminometer (Berthold FB12, Berthold, Pforzheim,
ermany) modified to maintain the sample temperature
t 37oC, as described and validated previously (13).
riefly, basal chemiluminescence from RAA homoge-
ates was measured after subtraction of the background
hemiluminescence of the lucigenin (5 mol/l)-
ontaining buffer. Further measurements were taken after
pplication of NADPH (100 mol/l). A single investi-
ator blinded to the patients’ post-operative outcome
erformed all measurements and analyses. Three basal
nd NADPH-stimulated measurements of superoxide
roduction were obtained and averaged for each patient.
Because it is well-established that high concentrations
f lucigenin 20 mol/l) are subject to redox cycling, we
13) have previously validated basal and NADPH-
timulated superoxide measurements in human atrial
amples obtained by using 5 mol/l lucigenin with those
btained by using the luminol analogue L-012 (in the
resence of ebselen) and the superoxide dismutase-
nhibitable ferricytochrome c reduction, respectively. In
oth cases measurements were closely correlated with
hose obtained in parallel by lucigenin-enhanced chemi-
Abbreviations
and Acronyms
AERP  atrial effective
refractory period
AF  atrial fibrillation
CABG  coronary artery
bypass grafting
CPB  cardiopulmonary
bypass
LVEF  left ventricular
ejection fraction
NADPH  nicotinamide
adenine dinucleotide
phosphate
NO  nitric oxide
RAA  right atrial
appendage
RLU  relative light units
ROS  reactive oxygen
species
SR  sinus rhythm
TBARS  thiorbabituric
acid-reactive substancesuminescence (basal measurements: r  0.88, p  0.005,
n
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Atrial NADPH Oxidase Activity and Post-Operative AF January 1/8, 2008:68–74 8; NADPH-stimulated: r  0.99, p  0.0001, n 
1). Specificity of this measurement for superoxide was
onfirmed by data showing near abolition of the chemi-
uminescence signal in the presence of specific scavengers
uch as superoxide dismutase or tiron both in right atrial
omogenates and in isolated atrial myocytes (13).
lasma markers of oxidative stress. Fasting blood samples
ere drawn from a central line immediately after the
nduction of anesthesia and 10 min after the administration
f protamine in 124 patients.
Thiorbabituric acid-reactive substances (TBARS), a
arker of lipid peroxidation, were measured in plasma using
previously described fluorometric technique (14,15). Co-
fficients of variation for within and between runs were 4%
nd 7%, respectively. Each sample was run in triplicate.
emodilution in post-operative samples was adjusted using
correction factor as described previously (16). Plasma
rotein carbonyl levels (a marker of protein oxidation) were
valuated using an enzyme-linked immunoadsorbent assay
ethod (17) and 8-isoprostane levels using a commercial
nzyme immunoassay kit (Cayman Chemical, Ann Arbor,
ichigan). Carbonyl content was calculated from the stan-
ard curve (prepared using oxidized and reduced bovine
erum albumin) and expressed as nmol carbonyl per mg of
mmunoglobulin. Adjusted (16) total (free and esterified)
-isoprostane levels in purified plasma samples taken after
PB and reperfusion are given in pg/ml. All measurements
ere carried out by a single investigator blinded to the
atients’ post-operative outcome.
tatistical analysis. Differences between patients who
eveloped AF and those who maintained sinus rhythm
SR) in the post-operative period were evaluated with a t
est or Wilcoxon rank sum test for continuous variables
nd a chi-square test for categorical variables. To identify
he subset of variables that predicted the occurrence of
ost-operative AF, we entered our variables in a logistic
egression model using block entry of variables (SPSS
3.0 for Windows, SPSS Inc., Cary, North Carolina).
riteria for entry and exclusion from this multivariate
nalysis were p  0.05 and p  0.10, respectively;
owever, variables had been shown to affect the occur-
ence of post-operative AF (i.e., use of beta-blockers or
nhibitors of the renin-angiotensin system [2] or the
ctivity of the cardiovascular NADPH oxidase, i.e., diabetes
ellitus [18] and treatment with statins [19]) were also entered
nto the model. Only main effects (i.e., no interaction terms)
ere fitted in this model. The association of atrial NADPH
xidase activity with post-operative AF was also assessed by
ategorization of the patients’ cohort into NADPH oxidase
ctivity quartiles. Data are presented as mean  SD or as
ercent of the total (%).
esults
eventy-one patients (42%) developed AF after CABG
urgery, and, as reported previously (1), the occurrence ofF was most common on the second and third post-
perative days. No significant differences between groups
ere found with respect to treatment, cardiovascular risk
actors and co-morbidity, duration of CPB or aortic cross-
lamp, and number of grafted vessels (Table 1). However,
atients who developed post-operative AF were slightly
lder and had a higher basal and NADPH-stimulated
uperoxide production than those who remained in SR
Fig. 1). In-hospital post-operative treatment with beta-
lockers was initiated in a similar percentage of patients from
ach group (i.e., in 63% of SR patients and in 69% of patients
ho developed AF, p 0.43); however, these agents tended to
e started slightly later in patients who developed AF after
urgery (Table 1). There was no difference in the post-
perative use of angiotensin-converting enzyme inhibitors or
ngiotensin II receptor blockers (i.e., these agents were initi-
ted in 67% of patients who remained in SR and 68% of
atients who developed AF, p  0.41) or in the time of
nitiation of treatment after surgery (Table 1).
Plasma levels of TBARS and protein carbonyls increased
ignificantly after reperfusion (Fig. 2), reflecting the increase
Figure 1 Basal and NADPH-Stimulated Superoxide Production
Box plots of basal and nicotinamide adenine dinucleotide phosphate (NADPH)-
stimulated superoxide production from right atrial appendage homogenates of
patients who remained in sinus rhythm (SR) (n  99) and those who devel-
oped atrial fibrillation (AF) post-operatively (n  71). The difference in basal
superoxide production between SR and AF patients did not quite reach statisti-
cal significance (p  0.07); however, NADPH-stimulated superoxide production
was significantly greater in patients who developed AF in the post-operative
period (*p  0.0001). RLU  relative light units.
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January 1/8, 2008:68–74 Atrial NADPH Oxidase Activity and Post-Operative AFn systemic oxidative stress associated with cardiac surgery.
owever, neither pre-operative nor post-operative plasma
evels of TBARS or protein carbonyl differed between
atients who developed AF and those who remained in SR
fter surgery (Fig. 2). Equally, the perioperative increase in
hese plasma markers of oxidative stress was not signifi-
antly associated with the occurrence of post-operative AF (p
0.31 for TBARS and p  0.45 for protein carbonyls).
imilar findings were obtained when post-operative plasma
evels of 8-isoprostane were compared (28.5  2.9 pg/ml in
atients who developed AF vs. 28.0  3.8 pg/ml in patients
ho remained in SR, p  0.86). There was no correlation
etween myocardial basal or NADPH-stimulated superoxide
roduction and plasma markers of oxidative stress (not shown).
Atrial NADPH-stimulated superoxide release increased
ith age (r  0.20, p  0.009) but was not significantly
ffected by pre-operative treatment with statins or inhibitors
f the angiotensin-converting enzyme/angiotensin II recep-
ors (p 0.36 and p 0.81, respectively), by left ventricular
jection fraction (LVEF) (p  0.52), or by the diagnosis of
iabetes mellitus (in relative light units [RLU]/s/g: 4.23
Figure 2 Plasma Levels of TBARS and Protein Carbonyls PRE
and POST Cardiopulmonary Bypass and Reperfusion
Box plots of plasma levels of thiorbabituric acid-reactive substances (TBARS)
and protein carbonyl before (PRE) and after (POST) cardiopulmonary bypass
and reperfusion in patients who remained in SR (n  71) and in those who
developed AF post-operatively (n  53). Thiorbabituric acid-reactive substances
and protein carbonyls increased significantly after reperfusion (*p  0.05 vs.
PRE for both); however, these markers did not differ between patients who
developed AF versus those who remained in SR. Abbreviations as in Figure 1..62 in patients with diabetes vs. 3.99 1.28 in nondiabetic ratients, n  43 and 127, respectively, p  0.33) or history
f congestive heart failure (p  0.89). In contrast, basal
uperoxide production from the RAA increased with the
everity of left ventricular dysfunction: a) 0.064  0.03
LU/s/g in patients with an LVEF 50%; b) 0.072 
.03 RLU/s/g in patients with an LVEF between 30% to
0%; and c) 0.089  0.05 RLU/s/g in patients with an
VEF 30%, n  83, 65, and 22, respectively; p  0.002
or a vs. c and p  0.04 for b vs. c) and was significantly
igher in patients with a clinical history of congestive heart
ailure (0.068  0.03 RLU/s/g vs. 0.086  0.05 RLU/
/g in patients with a history of congestive heart failure,
 149 and 21, respectively, p  0.02).
Multivariate analysis applied in a model-selection proce-
ure identified myocardial NADPH-stimulated superoxide
roduction as the most important independent predictor of
ost-operative AF in our patients (odds ratio 2.41; 95%
onfidence interval 1.71 to 3.40, p  0.0001) (Table 2); age
as no longer associated with an increased risk of post-
perative AF after the addition of NADPH-stimulated
uperoxide production to the model. Characterization of our
opulation according to quartiles of atrial NADPH-
timulated superoxide confirmed a strong association be-
ween these measurements and the occurrence of post-
perative AF (Table 3).
iscussion
his is the first prospective study to compare the potential
alue of myocardial and systemic markers of oxidative stress
n predicting the occurrence AF after CABG surgery. Our
ndings clearly show that NADPH-stimulated superoxide
roduction in the RAA is independently associated with an
ncreased risk of post-operative AF. Plasma markers of
xidative stress increased significantly after CPB and reper-
usion; however, neither pre-operative nor post-reperfusion
evels of plasma TBARS, protein carbonyl, or 8-isoprostane
iscriminated between patients who developed AF and
hose who maintained SR in the post-operative period.
hese findings indicate that ROS production in the atrial
yocardium may be a more accurate indicator of myocardial
xidative stress and its functional correlates (e.g., reduction
n AERP and arrhythmogenesis) (8,10,11) than systemic
arkers of oxidative stress and suggest that targeting tissue-
ultivariate Analysis
Table 2 Multivariate Analysis
OR 95% CI p Value
Age (yrs) 1.03 0.98–1.08 0.30
Diabetes (no/yes) 0.77 0.33–1.73 0.52
Post-operative beta-blockers (no/yes) 0.70 0.33–1.50 0.36
ACEI/ARB (no/yes) 0.65 0.30–1.39 0.27
Statins (no/yes) 1.78 0.50–6.44 0.38
NADPH-stimulated superoxide (RLU/s/g) 2.41 1.71–3.40 0.00001
ost-operative beta-blockers refers to patients who received treatment with beta-blockers before
ischarge. ACEI/ARB refers to patients who received treatment with ACEI or ARB before surgery.
CI  confidence intervals; NADPH  nicotinamide adenine dinucleotide phosphate; OR  odds
atio; other abbreviations as in Table 1.
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Atrial NADPH Oxidase Activity and Post-Operative AF January 1/8, 2008:68–74pecific sources of superoxide production may prove a more
uccessful therapeutic strategy than systemic antioxidant
nterventions.
xidative stress and AF. Myocardial oxidative damage is
ssociated with atrial electrophysiological remodeling and
igher inducibility of AF in animal models of rapid atrial
acing, both of which are prevented by treatment with high
oses of antioxidant or anti-inflammatory agents (8,10,11).
hese findings are not easily reconciled with the disappoint-
ng results of antioxidant vitamins trials in humans. Poor
atient selection and monitoring of the antioxidant effects of
reatment have been implicated in the therapeutic failure of
ntioxidant agents in humans (20). However, it is equally
lausible that interventions that are at least partially effective
n reducing plasma markers of lipid and protein oxidation in
umans may not lead to a significant reduction in oxidative
njury in the tissue of interest. This hypothesis is supported
y increasing evidence indicating that both myocardial and
ascular tissue contain constitutively active and highly mod-
lated oxidase systems and that local ROS production plays
n important role in the pathogenesis of common myocar-
ial disease states (12). Importantly, controlled clinical trials
ave recently demonstrated that interventions that prevent
ctivation of NADPH oxidases by vasoactive hormones or
nflammatory cytokines (i.e., angiotensin II receptor block-
rs [12], statins [21], or steroids [22]) are also highly
ffective in preventing the occurrence of AF in hypertensive
ubjects (23) and in patients after cardiac surgery (24,25).
ources of ROS in the human myocardium. Nicotin-
mide adenine dinucleotide phosphate oxidase–dependent
OS production in the myocardium or vessel wall has been
mplicated in the pathogenesis of a wide array of cardiovas-
ular diseases (12), including paroxysmal or chronic AF
13). As excess ROS production may lead both to nitric
xide (NO) scavenging (and the production of the powerful
ro-oxidant molecule peroxynitrite) and to ‘uncoupling’ of
O synthases (which causes these enzymes to produce
uperoxide rather than NO [26]), it remains unclear to
hich extent the pathophysiological correlates of increased
yocardial superoxide production are due to direct oxida-
ion of key proteins substrates or to a reduction in myocar-
ial NO bioavailability.
We have previously reported that a membrane-bound
OX2-containing NADPH oxidase is the main source of
OS production in the human atrial myocardium and isolated
ccurrence of Post-Operative AF Accordingo Q artiles f Atrial NADPH Oxidase Activity
Table 3 Occurrence of Post-Operative AF Accordingto Quartiles of Atrial NADPH Oxidase Activity
Quartiles of NADPH Oxidase Activity
First Second Third Fourth p for Trend
Post-operative AF, n (%) 5 (12) 15 (36) 23 (53) 28 (67) 0.00001
uartiles of NADPH oxidase activity (in RLU/s/g): first, 1.77 to 3.17; second, 3.18 to 3.81; third,
.82 to 4.76; fourth, 4.80 to 9.84.
AF  atrial fibrillation; NADPH  nicotinamide adenine dinucleotide phosphate; RLU  relative
ight units.trial myocytes (13). Here we show that atrial NADPH nxidase activity is an independent predictor of the occurrence
f post-operative AF. It could be argued that measurements in
AA samples obtained after reperfusion might have reflected
erioperative myocardial oxidative injury more accurately.
owever, NADPH oxidases have not been convincingly
mplicated with the oxidative stress that accompanies ischemia
nd reperfusion (27). Indeed, our preliminary data show no
ignificant difference in NADPH oxidase activity in RAA
amples obtained before CPB and shortly after reperfusion in
he same cohort of patients (unpublished data, Y. M. Kim,
ay 2005). In contrast, several vasoactive substances (e.g.,
ngiotensin II, endothelin I) and inflammatory mediators (e.g.,
nterleukin-6 and tumor necrosis factor-alpha) that are released
n response to cardiac surgery and CPB are now known to be
otent activators of cardiovascular NADPH oxidases (12).
hus, the perioperative inflammatory response may have a
ajor role in stimulating atrial NADPH oxidase activity,
hich, in turn, would increase myocardial oxidative stress
eading to electrophysiological changes (i.e., shortening of the
ERP [8]) that facilitate the new onset of AF in the early
ost-operative period. In other words, atrial NADPH oxidase
ay serve as an important link between systemic inflammation
nd tissue oxidative injury. In agreement with this hypothesis,
asal superoxide measurements did not differ between patients
ho maintained SR and those who developed AF after
urgery. Whereas superoxide production in response to
ADPH reflects the stimulated NADPH oxidase activity,
asal superoxide release results from the background activity of
everal oxidase systems and as such is less likely to bear a
elationship with the inflammation-driven post-operative
yocardial oxidative stress.
We considered that a lower signal-to-noise ratio may
ave contributed to our inability to detect significant differ-
nces in basal superoxide measurements between SR and
ost-operative AF patients; however, the use of a single vial
uminometer (modified to maintain our samples at a phys-
ological temperature) increases the sensitivity of this tech-
ique and largely circumvents the problems in detecting low
evels of superoxide that are encountered when using stan-
ard plate luminometers. Our observation that basal—but
ot NADPH-stimulated—atrial superoxide production in-
reased proportionally with the severity of left ventricular
ysfunction suggests that these measurements may reflect
ifferent pathophysiological mechanisms.
It is possible that atrial stretch and remodelling may affect
he activity of NADPH oxidases, which, in turn, may
ontribute to the recently reported association between
trial volume and post-operative AF (28). Unfortunately,
ecause the majority of patients who have cardiac surgery in
ur institution have their pre-operative assessment (e.g.,
oronary angiogram and echocardiography) elsewhere, we
id not have access to accurate echocardiographic measure-
ents of atrial volume; thus, the relationship between atrial
ize, NADPH oxidase activity, and post-operative AF could
ot be investigated.
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January 1/8, 2008:68–74 Atrial NADPH Oxidase Activity and Post-Operative AFPlasma markers of lipid and protein oxidation increased
ignificantly shortly after reperfusion, in agreement with the
otion that cardiac surgery and CPB increase systemic
xidative stress; however, neither marker predicted post-
perative AF. More robust indexes of lipid peroxidation,
uch as the determination of urinary levels of F2-
soprostanes by gas chromatography/mass spectrometry
29), might have provided a more accurate assessment of
ystemic oxidative stress in our patients; however, perform-
ng these complex and time-consuming measurements on a
arge scale is impractical and unlikely to detect myocardial
xidative stress as accurately as measurements of atrial
ADPH oxidase activity. In agreement with this hypoth-
sis, we found no significant correlation between measure-
ents of atrial superoxide production and plasma markers
f oxidative stress (not shown).
onclusions
e showed that atrial NADPH oxidase activity is indepen-
ently associated with an increased risk of AF in patients
ndergoing conventional CABG surgery, whereas the post-
perative rise in plasma markers of protein and lipid
xidation bears no association with this outcome. Our data
uggest that preventing the activation of cardiovascular-
pecific oxidases may be more effective in averting myocar-
ial oxidative injury and its functional consequences than
he systemic administration of antioxidant vitamins. Testing
his hypothesis may provide an important key for under-
tanding the role of oxidative stress in human cardiovascular
isease.
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